Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,197 | 194 | 97.4% |
| Education | $113.40 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $744.88 | 37 | $0 (2024) |
| Amgen Inc. | $539.56 | 22 | $0 (2024) |
| Horizon Therapeutics plc | $492.84 | 26 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $232.84 | 2 | $0 (2022) |
| Ardelyx, Inc. | $225.95 | 10 | $0 (2024) |
| PFIZER INC. | $218.59 | 14 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $213.50 | 6 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $196.76 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $165.38 | 8 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $136.70 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,005 | 47 | AstraZeneca Pharmaceuticals LP ($288.13) |
| 2023 | $914.43 | 45 | AstraZeneca Pharmaceuticals LP ($275.84) |
| 2022 | $501.22 | 15 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
| 2021 | $170.29 | 4 | Aurinia Pharma U.S., Inc. ($111.13) |
| 2020 | $624.36 | 27 | Amgen Inc. ($156.41) |
| 2019 | $435.20 | 18 | Amgen Inc. ($196.21) |
| 2018 | $288.23 | 18 | Horizon Pharma plc ($52.51) |
| 2017 | $371.56 | 23 | Fresenius USA Marketing, Inc. ($127.90) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.01 | General |
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Bone Health | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Nephrology | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Cardio-renal | ||||||
| 07/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 618 | 1,530 | $378,045 | $185,559 |
| 2022 | 17 | 656 | 1,728 | $426,300 | $221,083 |
| 2021 | 18 | 629 | 1,491 | $404,245 | $237,344 |
| 2020 | 18 | 663 | 1,597 | $389,244 | $204,792 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 44 | 333 | $166,500 | $79,732 | 47.9% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 36 | 161 | $72,450 | $26,066 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 235 | $41,125 | $20,002 | 48.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 21 | 146 | $26,280 | $17,258 | 65.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 124 | $16,120 | $12,230 | 75.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $13,400 | $9,404 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 85 | $10,625 | $5,504 | 51.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 121 | $12,100 | $5,018 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 30 | $7,800 | $4,214 | 54.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 20 | $2,000 | $1,366 | 68.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 41 | 41 | $2,050 | $1,301 | 63.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 31 | $2,480 | $1,290 | 52.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $900.00 | $882.00 | 98.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 24 | 29 | $2,175 | $645.48 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 56 | $840.00 | $470.40 | 56.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $1,200 | $177.24 | 14.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 61 | 435 | $208,350 | $107,335 | 51.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 45 | 167 | $71,600 | $26,404 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 187 | $31,570 | $16,337 | 51.7% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 28 | 144 | $24,920 | $14,944 | 60.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 153 | $18,960 | $13,218 | 69.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $15,000 | $10,759 | 71.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 40 | 175 | $12,250 | $8,691 | 71.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 42 | $10,730 | $6,536 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 86 | $10,565 | $5,112 | 48.4% |
About Dr. Thuc Tu, MD
Dr. Thuc Tu, MD is a Nephrology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699979229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thuc Tu, MD has received a total of $4,311 in payments from pharmaceutical and medical device companies, with $1,005 received in 2024. These payments were reported across 197 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,197).
As a Medicare-enrolled provider, Tu has provided services to 2,566 Medicare beneficiaries, totaling 6,346 services with total Medicare billing of $848,778. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Long Beach, CA
- Active Since 06/14/2007
- Last Updated 05/15/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1699979229
Products in Payments
- KRYSTEXXA (Biological) $523.28
- FARXIGA (Drug) $451.28
- LUPKYNIS (Drug) $232.84
- IBSRELA (Drug) $225.95
- Kerendia (Drug) $213.50
- LOKELMA (Drug) $196.15
- Vascepa (Drug) $165.38
- Aimovig (Biological) $150.14
- Not Product Related (Medical Supply) $140.83
- JYNARQUE (Drug) $136.70
- TARPEYO (Drug) $123.60
- Repatha (Biological) $122.75
- Ozempic (Drug) $103.38
- VIAGRA (Drug) $92.42
- Dayvigo (Drug) $90.14
- Auryxia (Drug) $78.80
- KRYSTEXXA (Drug) $69.64
- Prolia (Biological) $69.01
- Xofluza (Drug) $62.15
- EVENITY (Biological) $60.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Long Beach
Ngoc-Tram Tran, D.o, D.O
Nephrology — Payments: $8,583
Sapna Patel, Md, MD
Nephrology — Payments: $6,282
Dr. John Hsieh, M.d, M.D
Nephrology — Payments: $4,881
Arvind Mehta, Md, MD
Nephrology — Payments: $1,700
Essam Maasarani, M.d, M.D
Nephrology — Payments: $1,662
Dr. Karen Zoller, M.d, M.D
Nephrology — Payments: $1,524